Development of a high-throughput in vitro screening method for the assessment of cell-damaging activities of snake venoms.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
08 2023
08 2023
Historique:
received:
27
10
2022
accepted:
31
07
2023
revised:
29
08
2023
medline:
31
8
2023
pubmed:
17
8
2023
entrez:
17
8
2023
Statut:
epublish
Résumé
Snakebite envenoming is a globally important public health issue that has devastating consequences on human health and well-being, with annual mortality rates between 81,000 and 138,000. Snake venoms may cause different pathological effects by altering normal physiological processes such as nervous transfer and blood coagulation. In addition, snake venoms can cause severe (local) tissue damage that may result in life-long morbidities, with current estimates pointing towards an additional 450,000 individuals that suffer from permanent disabilities such as amputations, contractions and blindness. Despite such high morbidity rates, research to date has been mainly focusing on neurotoxic and haemotoxic effects of snake venoms and considerably less on venom-induced tissue damage. The molecular mechanisms underlaying this pathology include membrane disruption and extracellular matrix degradation. This research describes methods used to study the (molecular) mechanisms underlaying venom-induced cell- and tissue damage. A selection of cellular bioassays and fluorescent microscopy were used to study cell-damaging activities of snake venoms in multi-well plates, using both crude and fractionated venoms. A panel of 10 representative medically relevant snake species was used, which cover a large part of the geographical regions most heavily affected by snakebite. The study comprises both morphological data as well as quantitative data on cell metabolism and viability, which were measured over time. Based on this data, a distinction could be made in the ways by which viper and elapid venoms exert their effects on cells. We further made an effort to characterise the bioactive compounds causing these effects, using a combination of liquid chromatography methods followed by bioassaying and protein identification using proteomics. The outcomes of this study might prove valuable for better understanding venom-induced cell- and tissue-damaging pathologies and could be used in the process of developing and improving snakebite treatments.
Identifiants
pubmed: 37590328
doi: 10.1371/journal.pntd.0011564
pii: PNTD-D-22-01363
pmc: PMC10465002
doi:
Substances chimiques
Snake Venoms
0
Elapid Venoms
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0011564Informations de copyright
Copyright: © 2023 Bittenbinder et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Sci Rep. 2016 Nov 08;6:36629
pubmed: 27824133
Toxins (Basel). 2023 Apr 18;15(4):
pubmed: 37104232
Toxins (Basel). 2013 Nov 18;5(11):2172-208
pubmed: 24253238
Biochim Biophys Acta. 1975 Feb 27;379(2):317-28
pubmed: 1122290
Biochim Biophys Acta. 1977 Jul 22;493(1):216-27
pubmed: 880314
J Biol Chem. 1987 Oct 25;262(30):14402-7
pubmed: 3117784
Anal Bioanal Chem. 2018 Sep;410(23):5751-5763
pubmed: 30090989
Nat Rev Dis Primers. 2017 Sep 14;3:17063
pubmed: 28905944
Toxicon. 2003 Dec 15;42(8):915-31
pubmed: 15019491
BMC Microbiol. 2015 Feb 18;15:36
pubmed: 25881030
J Immunol Methods. 1997 May 26;204(2):205-8
pubmed: 9212838
Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):106-16
pubmed: 25450743
Toxicon. 2010 Nov;56(6):855-67
pubmed: 20670641
J Venom Anim Toxins Incl Trop Dis. 2017 Aug 8;23:38
pubmed: 28804495
Biochim Biophys Acta. 1998 Sep 8;1387(1-2):195-205
pubmed: 9748574
CRC Crit Rev Biochem. 1983;14(2):113-71
pubmed: 6340957
Toxins (Basel). 2016 Oct 22;8(10):
pubmed: 27782073
Cell Mol Life Sci. 2015 May;72(10):1939-58
pubmed: 25693678
J Proteomics. 2009 Jan 30;71(6):609-23
pubmed: 19026773
PLoS One. 2011;6(12):e28017
pubmed: 22174764
Curr Drug Targets. 2019;20(4):465-477
pubmed: 30360735
Pharmacol Ther. 1988;36(1):1-40
pubmed: 3277206
Protein Sci. 2007 Jun;16(6):1101-18
pubmed: 17525462
Cell Mol Life Sci. 2008 Sep;65(18):2897-912
pubmed: 18563294
Toxins (Basel). 2016 Jul 23;8(8):
pubmed: 27455326
Toxins (Basel). 2019 Mar 01;11(3):
pubmed: 30823637
Lancet. 2010 Jan 2;375(9708):77-88
pubmed: 20109866
J Clin Toxicol. 2014 Jan 25;4(1):1000181
pubmed: 24949227
Lancet. 2018 Aug 25;392(10148):673-684
pubmed: 30017551
Toxicon. 2003 Dec 15;42(8):827-40
pubmed: 15019485
Br J Haematol. 2017 Jun;177(6):947-959
pubmed: 28233897
Anal Bioanal Chem. 2017 Oct;409(25):5987-5997
pubmed: 28801827
PLoS Negl Trop Dis. 2020 Apr 1;14(4):e0007802
pubmed: 32236099
Toxicon. 2011 Nov;58(6-7):558-64
pubmed: 21924279
Toxins (Basel). 2016 Mar 26;8(4):93
pubmed: 27023608
Toxicon. 2002 Jun;40(6):659-65
pubmed: 12175601
J Biol Chem. 1997 Apr 4;272(14):9539-42
pubmed: 9083096
Eur J Biochem. 2000 Sep;267(17):5421-6
pubmed: 10951200
Biochem Biophys Res Commun. 1996 Jul 5;224(1):134-9
pubmed: 8694800
Front Pharmacol. 2020 May 07;11:611
pubmed: 32457615
PLoS Med. 2008 Nov 4;5(11):e218
pubmed: 18986210
J Proteome Res. 2023 Jun 2;22(6):1734-1746
pubmed: 37010854
Toxicol In Vitro. 2009 Apr;23(3):486-99
pubmed: 19159671
PLoS Negl Trop Dis. 2015 Apr 24;9(4):e0003731
pubmed: 25909592
Experientia. 1974 Feb 15;30(2):121-9
pubmed: 4592382
Toxicol Sci. 2003 Mar;72(1):122-9
pubmed: 12604841
Eur J Biochem. 1995 May 15;230(1):213-20
pubmed: 7601102
J Cell Sci. 2010 Dec 15;123(Pt 24):4195-200
pubmed: 21123617
Toxins (Basel). 2017 Sep 18;9(9):
pubmed: 28927001
J Mol Biol. 1994 May 27;239(1):122-36
pubmed: 8196041
World J Biol Chem. 2019 Jan 7;10(1):17-27
pubmed: 30622682
Toxicol In Vitro. 2004 Oct;18(5):703-10
pubmed: 15251189
J Biol Chem. 2003 Jun 13;278(24):21980-8
pubmed: 12660250
Bull Environ Contam Toxicol. 1994 Aug;53(2):309-16
pubmed: 8086717
Front Pharmacol. 2022 Jan 14;12:768015
pubmed: 35095489
Toxicon. 2008 Sep 1;52(3):508-17
pubmed: 18662711
Toxicon. 2013 Feb;62:3-18
pubmed: 23000249
PLoS One. 2009 Oct 22;4(10):e7497
pubmed: 19847301
Mol Cell Biochem. 2002 Nov;240(1-2):105-10
pubmed: 12487377